Trigeminal neuralgia: a systematic review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Scire Salutis |
Texto Completo: | https://sustenere.inf.br/index.php/sciresalutis/article/view/5698 |
Resumo: | Paroxysmal attacks of excruciating pain characterize trigeminal neuralgia, a clinical manifestation of an affection of the maxillary branch. It is considered one of the most severe and unbearable pains described by medicine, and can even lead to suicide. There is great difficulty in carrying out controlled therapeutic work on trigeminal neuralgia, as the cases are infrequent and it is unacceptable not to treat the patient in a placebo group. For this reason, the work in question aims to carry out a systematic review of the reports and descriptions existing in scientific journals. The present study consisted of a systematic review of the literature, with synthesis and analysis of clinical findings and meta-analysis of the quantitative data available in articles from indexed journals, both in Brazil and in other countries. Trigeminal neuralgia is a condition with pathophysiological mechanisms not fully understood. Drug therapy is considered the first-line treatment for NT. The anticonvulsant carbamazepine has been used since 1960 for its effectiveness in approximately 60% to 80% of patients. |
id |
ESS-1_f60c51c2494adf04012fa2251aa3c29f |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/5698 |
network_acronym_str |
ESS-1 |
network_name_str |
Scire Salutis |
repository_id_str |
|
spelling |
Trigeminal neuralgia: a systematic reviewNeuralgia do Trigêmeo: uma revisão sistemáticaAnatomiaNeuralgia do trigêmeoTratamentoAnatomyTrigeminal neuralgiaTreatmentParoxysmal attacks of excruciating pain characterize trigeminal neuralgia, a clinical manifestation of an affection of the maxillary branch. It is considered one of the most severe and unbearable pains described by medicine, and can even lead to suicide. There is great difficulty in carrying out controlled therapeutic work on trigeminal neuralgia, as the cases are infrequent and it is unacceptable not to treat the patient in a placebo group. For this reason, the work in question aims to carry out a systematic review of the reports and descriptions existing in scientific journals. The present study consisted of a systematic review of the literature, with synthesis and analysis of clinical findings and meta-analysis of the quantitative data available in articles from indexed journals, both in Brazil and in other countries. Trigeminal neuralgia is a condition with pathophysiological mechanisms not fully understood. Drug therapy is considered the first-line treatment for NT. The anticonvulsant carbamazepine has been used since 1960 for its effectiveness in approximately 60% to 80% of patients.Os ataques paroxísticos de dor lancinante caracterizam a neuralgia do trigêmeo, uma manifestação clínica de uma afecção do ramo maxilar. É considerada uma das dores mais graves e insuportáveis descritas pela medicina, podendo, inclusive, levar ao suicídio. Há grande dificuldade em se realizarem trabalhos terapêuticos controlados na neuralgia do trigêmeo, pois os casos são infrequentes e é inaceitável não tratar o paciente de um grupo-placebo. Por isso, o trabalho em questão objetiva realizar uma revisão sistemática sobre os relatos e descrições existentes nas revistas científicas. O presente estudo consistiu em uma revisão sistemática da literatura, com síntese e análise dos achados clínicos e meta-análise sobre os dados quantitativos disponíveis em artigos de periódicos indexados, tanto do Brasil como de outros países. A neuralgia trigeminal é uma afecção com mecanismos fisiopatológicos não inteiramente esclarecidos. A terapia medicamentosa é considerada o tratamento de primeira linha para a NT. O anticonvulsivante carbamazepina tem sido usado desde 1960 por sua eficácia em aproximadamente 60% a 80% dos pacientes.Sustenere Publishing2021-06-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://sustenere.inf.br/index.php/sciresalutis/article/view/569810.6008/CBPC2236-9600.2021.003.0018Scire Salutis; Vol. 11 No. 3 (2021): Scire Salutis - Jun, Jul, Ago, Set 2021; 136-141Scire Salutis; Vol. 11 Núm. 3 (2021): Scire Salutis - Jun, Jul, Ago, Set 2021; 136-141Scire Salutis; v. 11 n. 3 (2021): Scire Salutis - Jun, Jul, Ago, Set 2021; 136-1412236-9600reponame:Scire Salutisinstname:Companhia Brasileira de Produção Científica (CBPC)instacron:ESSporhttps://sustenere.inf.br/index.php/sciresalutis/article/view/5698/3058Copyright (c) 2021 Scire Salutishttp://creativecommons.org/licenses/by-nc-nd/4.0info:eu-repo/semantics/openAccess Lima, Bruno José SantosSandes, Maylla Fontes Pereira, Débora SilvaLima, Angela Santos Oliveira, Catharina Garcia deLopes, Gabriel Dantas Freitas, Ana Isabel Machado de Santos, Fernanda Bastos Andrade, Mariana Alma Rocha deMelo, Leonardo Santos2023-01-04T20:16:52Zoai:ojs.pkp.sfu.ca:article/5698Revistahttps://sustenere.co/index.php/sciresalutisONGhttps://sustenere.co/index.php/sciresalutis/oai||carlos@arvore.org.br2236-96002236-9600opendoar:2023-01-04T20:16:52Scire Salutis - Companhia Brasileira de Produção Científica (CBPC)false |
dc.title.none.fl_str_mv |
Trigeminal neuralgia: a systematic review Neuralgia do Trigêmeo: uma revisão sistemática |
title |
Trigeminal neuralgia: a systematic review |
spellingShingle |
Trigeminal neuralgia: a systematic review Lima, Bruno José Santos Anatomia Neuralgia do trigêmeo Tratamento Anatomy Trigeminal neuralgia Treatment |
title_short |
Trigeminal neuralgia: a systematic review |
title_full |
Trigeminal neuralgia: a systematic review |
title_fullStr |
Trigeminal neuralgia: a systematic review |
title_full_unstemmed |
Trigeminal neuralgia: a systematic review |
title_sort |
Trigeminal neuralgia: a systematic review |
author |
Lima, Bruno José Santos |
author_facet |
Lima, Bruno José Santos Sandes, Maylla Fontes Pereira, Débora Silva Lima, Angela Santos Oliveira, Catharina Garcia de Lopes, Gabriel Dantas Freitas, Ana Isabel Machado de Santos, Fernanda Bastos Andrade, Mariana Alma Rocha de Melo, Leonardo Santos |
author_role |
author |
author2 |
Sandes, Maylla Fontes Pereira, Débora Silva Lima, Angela Santos Oliveira, Catharina Garcia de Lopes, Gabriel Dantas Freitas, Ana Isabel Machado de Santos, Fernanda Bastos Andrade, Mariana Alma Rocha de Melo, Leonardo Santos |
author2_role |
author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Lima, Bruno José Santos Sandes, Maylla Fontes Pereira, Débora Silva Lima, Angela Santos Oliveira, Catharina Garcia de Lopes, Gabriel Dantas Freitas, Ana Isabel Machado de Santos, Fernanda Bastos Andrade, Mariana Alma Rocha de Melo, Leonardo Santos |
dc.subject.por.fl_str_mv |
Anatomia Neuralgia do trigêmeo Tratamento Anatomy Trigeminal neuralgia Treatment |
topic |
Anatomia Neuralgia do trigêmeo Tratamento Anatomy Trigeminal neuralgia Treatment |
description |
Paroxysmal attacks of excruciating pain characterize trigeminal neuralgia, a clinical manifestation of an affection of the maxillary branch. It is considered one of the most severe and unbearable pains described by medicine, and can even lead to suicide. There is great difficulty in carrying out controlled therapeutic work on trigeminal neuralgia, as the cases are infrequent and it is unacceptable not to treat the patient in a placebo group. For this reason, the work in question aims to carry out a systematic review of the reports and descriptions existing in scientific journals. The present study consisted of a systematic review of the literature, with synthesis and analysis of clinical findings and meta-analysis of the quantitative data available in articles from indexed journals, both in Brazil and in other countries. Trigeminal neuralgia is a condition with pathophysiological mechanisms not fully understood. Drug therapy is considered the first-line treatment for NT. The anticonvulsant carbamazepine has been used since 1960 for its effectiveness in approximately 60% to 80% of patients. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-06-22 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://sustenere.inf.br/index.php/sciresalutis/article/view/5698 10.6008/CBPC2236-9600.2021.003.0018 |
url |
https://sustenere.inf.br/index.php/sciresalutis/article/view/5698 |
identifier_str_mv |
10.6008/CBPC2236-9600.2021.003.0018 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://sustenere.inf.br/index.php/sciresalutis/article/view/5698/3058 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2021 Scire Salutis http://creativecommons.org/licenses/by-nc-nd/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2021 Scire Salutis http://creativecommons.org/licenses/by-nc-nd/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Sustenere Publishing |
publisher.none.fl_str_mv |
Sustenere Publishing |
dc.source.none.fl_str_mv |
Scire Salutis; Vol. 11 No. 3 (2021): Scire Salutis - Jun, Jul, Ago, Set 2021; 136-141 Scire Salutis; Vol. 11 Núm. 3 (2021): Scire Salutis - Jun, Jul, Ago, Set 2021; 136-141 Scire Salutis; v. 11 n. 3 (2021): Scire Salutis - Jun, Jul, Ago, Set 2021; 136-141 2236-9600 reponame:Scire Salutis instname:Companhia Brasileira de Produção Científica (CBPC) instacron:ESS |
instname_str |
Companhia Brasileira de Produção Científica (CBPC) |
instacron_str |
ESS |
institution |
ESS |
reponame_str |
Scire Salutis |
collection |
Scire Salutis |
repository.name.fl_str_mv |
Scire Salutis - Companhia Brasileira de Produção Científica (CBPC) |
repository.mail.fl_str_mv |
||carlos@arvore.org.br |
_version_ |
1793890278342393856 |